ARCHIVES

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

Moses, Wattenberg Lead AACR; NCI Budget Cut By $4.8 Mil. For Shannon Awards Contribution

May 24, 1991

Minority Professional Training Concept Gets Approval Of NCAB

March 1, 1991

NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics

March 26, 1999